These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28760905)

  • 1. A 2-Hydroxyisoquinoline-1,3-Dione Active-Site RNase H Inhibitor Binds in Multiple Modes to HIV-1 Reverse Transcriptase.
    Kirby KA; Myshakina NA; Christen MT; Chen YL; Schmidt HA; Huber AD; Xi Z; Kim S; Rao RK; Kramer ST; Yang Q; Singh K; Parniak MA; Wang Z; Ishima R; Sarafianos SG
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation and molecular modeling of 2-Hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymerase.
    Tang J; Vernekar SKV; Chen YL; Miller L; Huber AD; Myshakina N; Sarafianos SG; Parniak MA; Wang Z
    Eur J Med Chem; 2017 Jun; 133():85-96. PubMed ID: 28384548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of the allosteric inhibitor interaction on the HIV-1 reverse transcriptase RNase H domain.
    Christen MT; Menon L; Myshakina NS; Ahn J; Parniak MA; Ishima R
    Chem Biol Drug Des; 2012 Nov; 80(5):706-16. PubMed ID: 22846652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of Active-Site Inhibitor Interaction with HIV-1 RNase H.
    Xi Z; Wang Z; Sarafianos SG; Myshakina NS; Ishima R
    ACS Infect Dis; 2019 Nov; 5(11):1963-1974. PubMed ID: 31577424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of foamy virus reverse transcriptase by human immunodeficiency virus type 1 RNase H inhibitors.
    Corona A; Schneider A; Schweimer K; Rösch P; Wöhrl BM; Tramontano E
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4086-93. PubMed ID: 24798282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptase.
    Kirby KA; Marchand B; Ong YT; Ndongwe TP; Hachiya A; Michailidis E; Leslie MD; Sietsema DV; Fetterly TL; Dorst CA; Singh K; Wang Z; Parniak MA; Sarafianos SG
    Antimicrob Agents Chemother; 2012 Apr; 56(4):2048-61. PubMed ID: 22252812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase.
    Boyer PL; Smith SJ; Zhao XZ; Das K; Gruber K; Arnold E; Burke TR; Hughes SH
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6.
    Corona A; Meleddu R; Esposito F; Distinto S; Bianco G; Masaoka T; Maccioni E; Menéndez-Arias L; Alcaro S; Le Grice SF; Tramontano E
    PLoS One; 2016; 11(1):e0147225. PubMed ID: 26800261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.
    Corona A; Onnis V; Deplano A; Bianco G; Demurtas M; Distinto S; Cheng YC; Alcaro S; Esposito F; Tramontano E
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28859311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H.
    Kankanala J; Kirby KA; Huber AD; Casey MC; Wilson DJ; Sarafianos SG; Wang Z
    Eur J Med Chem; 2017 Dec; 141():149-161. PubMed ID: 29031062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel site.
    Himmel DM; Sarafianos SG; Dharmasena S; Hossain MM; McCoy-Simandle K; Ilina T; Clark AD; Knight JL; Julias JG; Clark PK; Krogh-Jespersen K; Levy RM; Hughes SH; Parniak MA; Arnold E
    ACS Chem Biol; 2006 Dec; 1(11):702-12. PubMed ID: 17184135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.
    Billamboz M; Bailly F; Barreca ML; De Luca L; Mouscadet JF; Calmels C; Andréola ML; Witvrouw M; Christ F; Debyser Z; Cotelle P
    J Med Chem; 2008 Dec; 51(24):7717-30. PubMed ID: 19053754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase.
    Tang J; Kirby KA; Huber AD; Casey MC; Ji J; Wilson DJ; Sarafianos SG; Wang Z
    Eur J Med Chem; 2017 Mar; 128():168-179. PubMed ID: 28182989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Hydroxypyrimidine-2,4-diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design, Synthesis, and Biochemical Evaluations.
    Tang J; Liu F; Nagy E; Miller L; Kirby KA; Wilson DJ; Wu B; Sarafianos SG; Parniak MA; Wang Z
    J Med Chem; 2016 Mar; 59(6):2648-59. PubMed ID: 26927866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.
    Shaw-Reid CA; Feuston B; Munshi V; Getty K; Krueger J; Hazuda DJ; Parniak MA; Miller MD; Lewis D
    Biochemistry; 2005 Feb; 44(5):1595-606. PubMed ID: 15683243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,2,4-Triazolo[1,5-
    Desantis J; Massari S; Corona A; Astolfi A; Sabatini S; Manfroni G; Palazzotti D; Cecchetti V; Pannecouque C; Tramontano E; Tabarrini O
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32151066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
    Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
    Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action.
    Esposito F; Mandrone M; Del Vecchio C; Carli I; Distinto S; Corona A; Lianza M; Piano D; Tacchini M; Maccioni E; Cottiglia F; Saccon E; Poli F; Parolin C; Tramontano E
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28637198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient kinetic analyses of the ribonuclease H cleavage activity of HIV-1 reverse transcriptase in complex with efavirenz and/or a β-thujaplicinol analogue.
    Herman BD; Sluis-Cremer N
    Biochem J; 2013 Oct; 455(2):179-84. PubMed ID: 23927736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of HIV-1 reverse transcriptase with the inhibitor beta-Thujaplicinol bound at the RNase H active site.
    Himmel DM; Maegley KA; Pauly TA; Bauman JD; Das K; Dharia C; Clark AD; Ryan K; Hickey MJ; Love RA; Hughes SH; Bergqvist S; Arnold E
    Structure; 2009 Dec; 17(12):1625-1635. PubMed ID: 20004166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.